Panitumumab - an effective long-term treatment for patients with metastatic colorectal cancer and wild-type KRAS status

Cancer Treat Rev. 2010 Feb:36 Suppl 1:S15-6. doi: 10.1016/S0305-7372(10)70003-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Disease Progression
  • Humans
  • Panitumumab
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins p21(ras)
  • Salvage Therapy / methods
  • ras Proteins / genetics*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • KRAS protein, human
  • Proto-Oncogene Proteins
  • Panitumumab
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins